New blood biomarker improves cancer risk detection in people with Lynch Syndrome
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can…
Mayo Clinic researchers develop experimental nanotherapy to treat aggressive brain tumors
Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, according to…
JMIR Publications’ new article showcases the transformative potential of precision oncology
JMIR Publications today announced the release of a timely new article in its News and Perspectives section, showcasing…
Metformin mimics exercise-related metabolic effects in prostate cancer patients
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise’s core…
Metabolic pathways drive progression from pancreatic lesions to cancer
Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer and has a low five-year survival rate.…
Tumor microenvironment drives resistance to ferroptosis in pancreatic cancer
Tumors driven by cancer-driving KRAS mutations are often susceptible to ferroptosis, a type of cell death that can…
Study explores racial differences in gastric cancer immunotherapy outcomes
Advanced gastric cancer remains one of the deadliest malignancies, with a 5-year overall survival rate below 10%. In…
Study reveals how inflammation disrupts lymph node structure in lymphoma
In aggressive lymphomas, inflammatory messengers reprogram the “conductors” of the immune system, causing lymph nodes structure to collapse.…
Healthy thymus gland linked to longer life and immune stability
People with a healthy thymus gland live longer and are less likely to fall ill. In addition, immunotherapies…
Study links androgens to aggressive childhood brain tumor growth
An international team led by researchers at Baylor College of Medicine, Texas Children’s Hospital, McGill University and University…
New guidance aims to standardize tumor mutational burden in cancer
Immune checkpoint inhibitors have transformed cancer care, yet only a minority of patients respond to monotherapy, and immune-related…
Blood pressure drug boosts effectiveness of cancer therapy
In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP,…